Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer

References

• Alyafee Y, Alaamery M, Bawazeer S, et al. (2018). Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines. Int J Nanomed 13:199–208.
   PubMed Web of Science ®Google Scholar
• Arbour K, Riely G. (2019). Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA 322:764–74.
   PubMed Web of Science ®Google Scholar
• Asadi H, Rostamizadeh K, Salari D, et al. (2011). Preparation and characterization of tri-block poly(lactide)-poly(ethylene glycol)-poly(lactide) nanogels for controlled release of naltrexone. Int J Pharm 416:356–64.
   PubMed Web of Science ®Google Scholar
• Barker H, Paget J, Khan A, et al. (2015). The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409–25.
   PubMed Web of Science ®Google Scholar
• Biffi S, Voltan R, Bortot B, et al. (2019). Actively targeted nanocarriers for drug delivery to cancer cells. Expert Opin Drug Deliv 16:481–96.
   PubMed Web of Science ®Google Scholar
• Budker V, Monahan S, Subbotin V. (2014). Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction. Drug Discov Today 19:1855–70.
   PubMed Web of Science ®Google Scholar
• Chen J, Ning E, Wang Z, et al. (2021). Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy. Drug Deliv 28:1389–96.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Meyers J, Agnes R, et al. (2011). Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? Small 7:2301–6.
   PubMed Web of Science ®Google Scholar
• Dewhirst M, Secomb T. (2017). Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer 17:738–50.
   PubMed Web of Science ®Google Scholar
• Engelberg S, Netzer E, Assaraf Y, et al. (2019). Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo. Cell Death Dis 10:702.
   PubMed Web of Science ®Google Scholar
• Fokas E, Im J, Hill S, et al. (2012). Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature. Cancer Res 72:239–48.
   PubMed Web of Science ®Google Scholar
• Gallo G, Vescio G, De Paola G, et al. (2021). Therapeutic targets and tumor microenvironment in colorectal cancer. J Clin Med 10:2295.
   PubMed Web of Science ®Google Scholar
• Kim S, Jung K, Son M, et al. (2017). Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery. Cancer Lett 403:339–53.
   PubMed Web of Science ®Google Scholar
• Kunjachan S, Detappe A, Kumar R, et al. (2015). Nanoparticle mediated tumor vascular disruption: a novel strategy in radiation therapy. Nano Lett 15:7488–96.
   PubMed Web of Science ®Google Scholar
• Li M, Deng L, Li J, et al. (2018). Actively targeted magnetothermally responsive nanocarriers/doxorubicin for thermochemotherapy of hepatoma. ACS Appl Mater Interfaces 10:41107–17.
   PubMed Web of Science ®Google Scholar
• Li X, Qiu L, Zhu P, et al. (2012). Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting. Small (Weinheim an Der Bergstrasse, Germany) 8:2505–14.
   PubMed Web of Science ®Google Scholar
• Li S, Xu S, Liang X, et al. (2021). Nanotechnology: breaking the current treatment limits of lung cancer. Adv Healthc Mater 10:e2100078.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H. (2019). Nanoparticle-based drug delivery systems for enhanced tumor-targeting treatment. J Biomed Nanotechnol 15:1–27.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhou Y, He W, et al. (2021). Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis. J Control Release 338:33–45.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang X, He D, et al. (2021). Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine 80:153402.
   PubMed Web of Science ®Google Scholar
• Massadeh S, Almohammed I, Barhoush E, et al. (2021). Development of epirubicin-loaded biocompatible polymer PLA-PEG-PLA nanoparticles: synthesis, characterization, stability, and in vitro anticancerous assessment. Polymers 13:1212.
   PubMed Web of Science ®Google Scholar
• Matarrese P, Mattia G, Pagano M, et al. (2021). The sex-related interplay between tme and cancer: on the critical role of estrogen, microRNAs and autophagy. Cancers 13:3287.
   PubMed Web of Science ®Google Scholar
• Miller M, Chandra R, Cuccarese M, et al. (2017). Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Sci Transl Med 9:eaal0225.
   Web of Science ®Google Scholar
• Miller M, Zheng Y, Gadde S, et al. (2015). Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun 6:8692.
   PubMed Web of Science ®Google Scholar
• Mohanty R, Liu X, Ghosh D. (2020). Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix. Acta Biomater 113:240–51.
   PubMed Web of Science ®Google Scholar
• Mohtar N, Parumasivam T, Gazzali A, et al. (2021). Advanced nanoparticle-based drug delivery systems and their cellular evaluation for non-small cell lung cancer treatment. Cancers 13:3539.
   PubMed Web of Science ®Google Scholar
• Overchuk M, Zheng G. (2018). Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 156:217–37.
   PubMed Web of Science ®Google Scholar
• Potiron V, Clément-Colmou K, Jouglar E, et al. (2019). Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy. Cancer Lett 457:1–9.
   PubMed Web of Science ®Google Scholar
• Qian X, Ge L, Yuan K, et al. (2019). Targeting and microenvironment-improving of phenylboronic acid-decorated soy protein nanoparticles with different sizes to tumor. Theranostics 9:7417–30.
   PubMed Web of Science ®Google Scholar
• Qin X, Zhang M, Hu X, et al. (2021). Nanoengineering of a newly designed chlorin e6 derivative for amplified photodynamic therapy via regulating lactate metabolism. Nanoscale 13:11953–62.
   PubMed Web of Science ®Google Scholar
• Rosenblum D, Joshi N, Tao W, et al. (2018). Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9:1410.
   PubMed Web of Science ®Google Scholar
• Shang Q, Zhou S, Zhou Z, et al. (2021). Dual cancer stem cell manipulation to enhance phototherapy against tumor progression and metastasis. J Control Release 340:282–91.
   PubMed Web of Science ®Google Scholar
• Shimizu R, Ibaragi S, Eguchi T, et al. (2019). Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma. Int J Oncol 54:283–94.
   PubMed Web of Science ®Google Scholar
• Stapleton S, Jaffray D, Milosevic M. (2017). Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery. Adv Drug Deliv Rev 109:119–30.
   PubMed Web of Science ®Google Scholar
• Tang S, Li S, Liu T, et al. (2021). MicroRNAs: emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer. Cancer Lett 502:71–83.
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivée B. (2017). Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 20:409–26.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu P, Qiu L, et al. (2013). Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice. Biomaterials 34:4068–77.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhao Y, Miao L, et al. (2016). Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer. J Control Release 244:63–73.
   PubMed Web of Science ®Google Scholar
• Yang S, Tang Z, Zhang D, et al. (2017). pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin. Biomater Sci 5:2169–78.
   PubMed Web of Science ®Google Scholar
• Yu X, Jin X, Shou Z. (2021). Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices. Drug Deliv 28:1995–2010.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang F, Ren C, et al. (2017). Targeted chemo-photodynamic combination platform based on the DOX prodrug nanoparticles for enhanced cancer therapy. ACS Appl Mater Interfaces 9:13016–28.
   PubMed Web of Science ®Google Scholar
• Zhang M, Qin X, Xu W, et al. (2021). Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy. J Colloid Interface Sci 594:493–501.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Han Y, et al. (2010). Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels. Int J Pharm 386:15–22.
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu W, Lan Y, et al. (2019). Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer. Int J Nanomed 14:5287–301.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu W, Tian Y, et al. (2018). Anti-EGFR peptide-conjugated triangular gold nanoplates for computed tomography/photoacoustic imaging-guided photothermal therapy of non-small cell lung cancer. ACS Appl Mater Interfaces 10:16992–7003.
   PubMed Web of Science ®Google Scholar